Image

Home>Vaccination Services> Seasonal Influenza Vaccine

2025/26
Seasonal Influenza Vaccine

Influenza occurs in Hong Kong throughout the year. Seasonal influenza refers to the viruses that circulate in the human population and cause widespread illnesses especially during each influenza season.
To ensure the safety of yourself and your loved ones, it is crucial to familiarize yourself with the seasonal influenza vaccine. Take proactive measures now by staying informed about the available seasonal influenza vaccine options.

What is the recommended composition of the 2025-26 seasonal influenza vaccine?
The egg-based quadrivalent influenza vaccine recommended by the Scientific Committee on Vaccine Preventable Diseases (SCVPD) for the 2025-26 season contain the following:

an A/Victoria/4897/2022 (H1N1)pdm09-like virus
an A/Croatia/10136RV/2023 (H3N2)-like virus
a B/Austria/1359417/2021(B/Victoria lineage)-like virus
a B/Phuket/3073/2013(B/Yamagata lineage)-like virus
If egg-based trivalent influenza vaccine is being used, the influenza B component shall contain a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

The cell culture or recombinant based quadrivalent influenza vaccine recommended by the SCVPD for the 2025-26 season contain the following:

an A/Wisconsin/67/2022 (H1N1)pdm09-like virus
an A/District of Columbia/27/2023 (H3N2)-like virus
a B/Austria/1359417/2021(B/Victoria lineage)-like virus
a B/Phuket/3073/2013(B/Yamagata lineage)-like virus
If cell culture or recombinant based trivalent influenza vaccine is being used, the influenza B component shall contain a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

 

Which type of flu vaccine is more suitable for me?

The following 3 vaccines are recommended for use in Hong Kong by the Scientific Committee on Vaccine Preventable Diseases:

Inactivated Influenza (IIV)

Recombinant Influenza Vaccine (RIV)

Live Attenuated Influenza Vaccine (LAIV)

Inactivated Influenza Vaccine Recombinant Influenza Vaccine Live Attenuated Influenza Vaccine
Vaccine Type Contains killed (inactivated) virus Contains recombinant protein Contains weakened live virus
Administration Intramuscular injection Intramuscular injection Nasal spray
Suitable for 6 months and above 18 years and above; (Research shows it offers a 30% higher protection level for individuals aged >50 compared to other vaccines.) Ages 2 to 49
Doses For persons aged 9 years or above, only one dose of SIV is required in each influenza season.
Children aged 6 months to under 9 years who have never received any seasonal influenza vaccination (SIV) before are recommended to receive 2 doses of SIV with a minimum interval of 28 days in the current season. Children aged below 9 years who have received at least one dose of SIV before are recommended to receive one dose of SIV in the current season.
Pregnant women and immunocompromised individuals Suitable Suitable Should not be used in
Common side effects Pain, redness and swelling at the site of injection. Some recipients may experience fever, chills, muscle pain and tiredness. Pain, redness and swelling at the site of injection. Some recipients may also experience fever, chills, muscle pain and tiredness. Mild nasal congestion or runny nose, low-grade fever and sore throat.

The above information is for reference only. Consult a medical professional for specific recommendations.

*Eligible individuals must provide relevant documentation for the government subsidy programme. Visit the Centre for Health Protection’s website for more details.

Does vaccination offer immediate flu protection?

No! It takes about two weeks after vaccination for antibodies to develop in the body and provide protection against influenza virus infection.
Get vaccinated now!

The difference between Trivalent and Quadrivalent Influenza Vaccines

The trivalent formulation includes antigens for two influenza A subtypes (H1N1 and H3N2) and one influenza B virus (Victoria lineage) while the quadrivalent formulation has antigens for two influenza A and two influenza B viruses (Victoria and Yamagata lineages). Based on the World Health Organisation surveillance data, B/Yamagata lineage viruses are no longer circulating in the population.
Both vaccines are effective in preventing influenza and its complications together with reduction in influenza-associated hospitalisation and death and have excellent safety profiles.

 
FAQ about Influenza Vaccines

Why should I get vaccinated against the flu?

Seasonal influenza vaccination (SIV) is one of the effective means in preventing influenza and its complications together with reduction in influenza-associated hospitalisation and death.

When should I get the seasonal influenza vaccine?

Since it takes about two weeks after vaccination for antibodies to develop in the body and provide protection against influenza virus infection, it is advised to get vaccinated at least two weeks before the arrival of winter influenza season. However, even if seasonal influenza vaccination is not received before the winter influenza season, it can still be received as soon as possible.

How many doses of influenza vaccine should be administered each year?

For persons aged 9 years or above: One dose per year.

Children aged 6 months to under 9 years: Two doses for the initial vaccination, with a 28 days interval between each dose. Subsequently, one dose should be administered each year.

Is it necessary to get the influenza vaccine every year?

Seasonal influenza vaccination requires annual administration. Evidence on repeated influenza vaccination shows that vaccination in the current and prior season provides better protection than no vaccination or being vaccinated in the prior season only. Furthermore, the circulating seasonal influenza strains may change from time to time and the vaccine composition is updated every year in accordance with the circulating strains to enhance protection.

Terms and Conditions
  1. Prior appointment is required before using the service
  2. Service Location ﹕
    A) Self-paid vaccination
    Hong Kong Island - 9/F, Virtus Medical Tower, 122 Queen’s Road Central, Central, Hong Kong
    Kowloon - 11/F, H Zentre, 15 Middle Road, Tsim Sha Tsui, Kowloon
    B) Eligible for the Government’s Vaccination Subsidy Scheme vaccination
    Hong Kong Island - 5/F, Virtus Medical Tower, 122 Queen’s Road Central, Central, Hong Kong
    Kowloon - 11/F, H Zentre, 15 Middle Road, Tsim Sha Tsui, Kowloon
  3. Those eligible for the Government’s Vaccination Subsidy Scheme must present relevant supporting documents. For details, please visit Centre for Health Protection - Department of Health.

 

Reference:
1. Centre of Health Proctection Frequently Asked Questions on Seasonal Influenza Vaccination for the 2025-26 Season in Hong Kong
https://www.chp.gov.hk/en/features/100764.html

Last Update:
18th Sep 2025